Claims for Patent: 8,258,273

Summary for Patent: 8,258,273

Title:	Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P
Abstract:	The invention is directed to an isolated genomic polynucleotide fragment that encodes human soluble (cytosolic) aminopeptidase P, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human soluble aminopeptidase P and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s):	Ryan; James W (Augusta, GA)
Assignee:	Ryogen LLC (N/A)
Application Number:	11/757,379
Patent Claims:	1. An isolated polynucleotide sequence consisting of at least 500 contiguous nucleotides from an intron region between nucleotides 25679-28128 of SEQ ID NO:2. 2. An isolated polynucleotide sequence consisting of nucleotides 27558-27958 of SEQ ID NO:2. 3. An isolated polynucleotide sequence consisting of between 50-400 contiguous nucleotides from a region of the isolated polynucleotide sequence of claim 2. 4. A kit comprising the isolated polynucleotide sequence of claim 1. 5. A method of detecting the presence or absence of a polynucleotide having a nucleic acid sequence set forth depicted in SEQ ID NO:2 or its complementary sequence in a sample, said method comprising (a) hybridizing the sample with a polynucleotide of claim 1, and (b) determining whether the polynucleotide binds to a polynucleotide sequence in the sample, wherein binding of a polynucleotide of the sample to a polynucleotide of claim 2 detects the presence of a polynucleotide comprising SEQ ID NO:2. 6. A kit comprising the isolated polynucleotide sequence of claim 3. 7. A method of detecting the presence or absence of a polynucleotide having a nucleic acid sequence set forth depicted in SEQ ID NO:2 or its complementary sequence in a sample, said method comprising (a) hybridizing the sample with a polynucleotide of claim 3 and (b) determining whether the polynucleotide binds to a polynucleotide sequence in the sample, wherein binding of a polynucleotide of the sample to a polynucleotide of claim 3 detects the presence of a polynucleotide comprising SEQ ID NO:2. 8. The method according to claim 7, wherein said sample is hybridized with said polynucleotide under stringent conditions. 9. A method of identifying a variant of SEQ ID NO:2 or its complementary sequence comprising (a) isolating genomic DNA from a subject and (b) determining the presence or absence of a variant in said genomic DNA using the polynucleotide of claim 1. 10. A microarray comprising one of more polynucleotides of claim 1. 11. The microarray according to claim 10, wherein one or more polynucleotides are labeled with a detectable substance. 12. The microarray of claim 10, wherein said microarray comprises an exon region of SEQ ID NO:2. 13. A kit comprising the microarray of claim 10. 14. A microarray comprising one of more polynucleotides of claim 3. 15. The microarray according to claim 14, wherein one or more polynucleotides are labeled with a detectable substance. 16. The microarray of claim 14, wherein said microarray comprises an exon region of SEQ ID NO:2. 17. A kit comprising the microarray of claim 14. 18. The polynucleotide according to claim 3, wherein said polynucleotide is in the form of DNA. 19. The polynucleotide according to claim 3, wherein said polynucleotide is in the form of RNA. 20. The method according to claim 9, wherein said method comprises determining the presence or absence of a variant of a 5'-noncoding region, 3'-noncoding region or intron regions of SEQ ID NO:2. 21. A method of identifying a variant of SEQ ID NO:2. or its complementary sequence comprising: (a) isolating genomic DNA from a subject and (b) determining the presence or absence of a variant in said genomic DNA using the polynucleotide of claim 2. 22. The method according to claim 21, wherein said method comprises determining the presence or absence of a variant of a 5'-noncoding region, 3'-noncoding region or intron regions of SEQ ID NO:2. 23. A method of identifying a variant of SEQ ID NO:2. or its complementary sequence comprising: (a) isolating genomic DNA from a subject and (b) determining the presence or absence of a variant in said genomic DNA using the polynucleotide of claim 3. 24. The method according to claim 23, wherein said method comprises determining the presence or absence of a variant of a 5'-noncoding region, 3'-noncoding region or intron regions of SEQ ID NO:2.

Details for Patent 8,258,273

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2022-06-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2022-06-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2022-06-07